New study to test antifungal drug in patients with liver issues and deadly fungal infection
NCT ID NCT07337720
First seen Jan 18, 2026 · Last updated May 20, 2026 · Updated 26 times
Summary
This study looks at how safe and effective the antifungal drug liposomal amphotericin B is for patients with a severe fungal infection called invasive aspergillosis who also have liver problems. The study will enroll 40 adults in intensive care in China. Researchers will measure how well the infection responds to treatment and survival rates over 6 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASPERGILLOSIS INVASIVE are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.